Abstract:AIM:To study the effects of exogenous bone mesenchymal stem cell(BMSC) transplantation on silicosis fibrosis in rats,and to explore the dose-effect relationship.METHODS: BMSCs were isolated and cultured from male 5-week-old SD rats in vitro.Fifty healthy female SD rats were randomly divided into 5 groups: control group,silicosis model group,BMSCs treatment A group(1×109 cells/L),BMSCs treatment B group(3×109cells/L) and BMSCs treatment C group(5×109 cells/L).The silicosis model was made by one-time infusion of silica dust suspension using the non-exposed tracheal intubation,and different doses of BMSCs were given for intervention therapy.All the rats were sacrificed on the 21st day after the model was established.The morphological changes of the lung tissues were observed by HE staining and Masson staining.The localization and distribution of tumor necrosis factor α(TNF-α) and transforming growth factor β(TGF-β) were determined by the method of immunohistochemistry.The protein levels of TNF-α,TGF-β,collagen type I and collagen type ⅡI were detected by Western blotting.The sex-determining region(SRY) protein was searched by an immunofluorescence method to confirm the homing of BMSCs.RESULTS: Compared with control group,the silicosis model group had significant alveolitis changes,silicon nodule formation,collagen deposition and other pathological characteristics.Compared with silicosis model group,the pathological changes in BMSCs treatment A group were improved.The conditions of BMSCs treatment B group were also improved significantly.However,the pathological changes in BMSCs treatment C group were increased obviously.The protein levels of TNF-α,TGF-β,collagen type I and collagen type ⅡI in the lung tissues ranked as follows: BMSCs treatment C group > silicosis model group > BMSCs treatment A group > BMSCs treatment B group > control group.The difference between BMSCs treatment C group and silicosis model group was not statistically significant,and the differences between the other groups were statistically significant.The SRY-positive cells were observed in BMSCs treatment B group,but no significant expression in the heart,liver,spleen and kidney tissues was observed.CONCLUSION: The exogenous BMSC transplantation antagonizes the development of silicosis fibrosis in rats,which has dose-effect relationship.

Exosomes derived from bone marrow mesenchymal stem cells reverse epithelial-mesenchymal transition potentially via attenuating Wnt/β-catenin signaling to alleviate silica-induced pulmonary fibrosis

Exosomes derived from three-dimensional cultured human umbilical cord mesenchymal stem cells ameliorate pulmonary fibrosis in a mouse silicosis model

Therapeutic effect of exogenous bone marrow‑derived mesenchymal stem cell transplantation on silicosis via paracrine mechanisms in rats.

Macrophage‐derived exosomes mediate silica‐induced pulmonary fibrosis by activating fibroblast in an endoplasmic reticulum stress‐dependent manner

XAV‐939 inhibits epithelial‐mesenchymal transformation in pulmonary fibrosis induced by crystalline silica via the Wnt signaling pathway

Human embryonic stem cell‐derived mesenchymal stem cell secretome reverts silica‐induced airway epithelial cell injury by regulating Bmi1 signaling

Exosomal Let-7I-5p from Three-Dimensional Cultured Human Umbilical Cord Mesenchymal Stem Cells Inhibits Fibroblast Activation in Silicosis Through Targeting TGFBR1.

Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats

Mesenchymal Stem Cell-Derived Exosomes Attenuate Epithelial-Mesenchymal Transition of HK-2 Cells.

[Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Alleviate Pulmonary Fibrosis in Mice by Inhibiting Epithelial-Mesenchymal Transition].

Exosomal miR-218 derived from mesenchymal stem cells inhibits endothelial-to-mesenchymal transition by epigenetically modulating of BMP2 in pulmonary fibrosis

Effects of bone mesenchymal stem cell transplantation on silicosis fibrosis in rats

Mesenchymal stem cells-extracellular vesicles alleviate pulmonary fibrosis by regulating immunomodulators

Therapeutic Effects of Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells on Epithelial-Mesenchymal Transition in A549 Cells.

Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury

miR-138 inhibits epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by regulating ZEB2

Exposure to micron-grade silica particles triggers pulmonary fibrosis through cell-to-cell delivery of exosomal miR-107

Anti-inflammatory protein TSG-6 secreted by BMSCs attenuates silica-induced acute pulmonary inflammation by inhibiting NLRP3 inflammasome signaling in macrophages

Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats

Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway